Back to company

LABEX ApS: Financial statements 2024

CVR: 19947394

LABEX ApS (CVR 19947394) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,455,920 and a net result of DKK 17,641 compared with DKK 74,128 the year before. That is a decrease of 40.8% compared with the year before. Equity amounted to DKK 791,943. The solvency ratio was 31%. The company had 1 employee in the financial year.

Gross Profit
1,455,920 kr.
Profit/Loss
17,641 kr.
Equity
791,943 kr.
Total Assets
2,550,568 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-1.5 mio.18 t.792 t.1
2023-2.5 mio.74 t.774 t.3
2022-2.4 mio.-155 t.700 t.3
2021-2.1 mio.188 t.855 t.2
2020-778 t.-835 t.667 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is LABEX ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

LABEX ApS wins public contractMay 17, 2024

LABEX ApS has won the tender "Udstyr og reagenser til manuelle blodtypeserologiske undersøgelser samt mærkater til bestrålede blodkomponenter og pipettespidser til automatiseret udstyr" issued by Region Syddanmark worth 6,800,000 DKK.

LABEX ApS wins public contractApr 15, 2024

LABEX ApS has won the tender "Blodbestrålere til KIA, OUH, Odense Universitetshospital" issued by Region Syddanmark.

About LABEX ApS

LABEX ApS is a Danish company of the type Anpartsselskab based in Valby, founded in 1996. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Max Pihlqvist. The company is owned by Svenska Labex AB. The company has 1 employee. In 2026, the company reported a gross profit of DKK 1,909,444 and a net result of DKK 991,782 compared with DKK 5,318 the year before. Equity amounted to DKK 1,789,042.